The Panoramic Trial Reaches 20,000 Enrolments!
“We want to thank everyone who has taken part in the PANORAMIC trial to date. Your vital contribution to this remarkable study will provide key evidence in record time for a potentially game-changing class of new COVID-19 treatments.”
Over twenty thousand participants from right across the UK have now taken part in the NIHR-funded and supported PANORAMIC trial - the world’s largest study into new antiviral treatments against COVID-19 in community, ambulatory care.
This trial was recently launched in December last year but only took a few months to reach this milestone. It is also believed to be the world’s largest study of community-based treatments for acute COVID-19, in addition to the UK’s fastest ever recruiting interventional trial delivered through primary care.
Our Spiral software is helping the trial to rapidly generate evidence on which of the people suffering with COVID-19 at home and in the community are helped the most by the new antiviral treatments. All without needing to be treated in hospital.
More in depth information on the Panoramic trial and its progress can be found here via NIHR.
